# Session Notes

## Stock Tracking

### Screening Candidates — Daily Digests

#### Losers / Dislocation
- **KD** (Kyndryl) — -55%, CFO/GC/Controller exits + SEC doc request + guidance slashed [Feb 9-10]
- **STLA** (Stellantis) — -25%, billions in EV write-downs, no dividend [Feb 6]
- **MAT** (Mattel) — -22%, guidance miss + tariff warning while rival Hasbro at 6yr high [Feb 11]
- **IT** (Gartner) — -21%, AI-fear selloff on data provider disruption thesis [Feb 3]
- **CLVT** (Clarivate) — -20%, same AI-fear selloff as IT [Feb 3]
- **HUBG** (Hub Group) — -18%, $77M financial reporting error [Feb 6]
- **HIMS** (Hims & Hers) — -16%, sued by Novo Nordisk over unapproved obesity drug copies [Feb 9]
- **DIS** (Disney) — -5%, stock down on CEO succession despite record Parks revenue [Feb 3]
- **SPGI** (S&P Global) — bear market territory after mixed Q4, AI-driven concerns [Feb 10]
- **NVO** (Novo Nordisk) — continued decline on U.S. pricing pressure warnings [Feb 4]
- **QCOM** (Qualcomm) — memory crunch forcing phone production cuts [Feb 5]
- **ARM** (ARM Holdings) — same memory crunch signal as QCOM [Feb 5]
- **CVNA** (Carvana) — off-the-books transaction files with DriveTime ordered released; "Enron of auto" narrative [Feb 11]
- **Software Basket** [Feb 11] — heavy short interest + stabilizing prices = squeeze potential. Goldman/Blackstone say selloff "overblown."
  - ADBE (Adobe), CRM (Salesforce), CRWD (CrowdStrike), NOW (ServiceNow), PANW (Palo Alto Networks), SNOW (Snowflake), WDAY (Workday), ZS (Zscaler)

#### Momentum / Other
- **ICHR** (Ichor Holdings) — +35% on earnings beat, needs cash flow validation [Feb 10]
- **VRT** (Vertiv) — beat on data center infra (power/cooling), stock soaring [Feb 11]
- **ENPH** (Enphase Energy) — +24% surge after beating expectations [Feb 4]
- **ORCL** (Oracle) — +9.6% on OpenAI/TikTok partnerships; $50B equity/debt raise [Feb 2, 9]
- **MU** (Micron) — memory squeeze beneficiary, AI supply chain [Feb 2, 6]
- **NIO** (NIO) — first quarterly profit, stock jumped; needs OCF vs NI check [Feb 5]
- **CEK** (Ceotronics) — German military supplier "Hidden Champion," potential new orders [Feb 2]
- **GLD/SLV** — precious metals breakout, gold +6.1%, silver +8.2%; largest % gain since 2009 [Feb 3]

### Screening Candidates — Other Sources

#### Losers / Dislocation
- **QVCGA** (Qurate Retail) — -46%
- **UPWK** (Upwork) — -15%
- **ABCL** (AbCellera) — down double digits on AI pharma disruption fears (KeyBanc)
- **ABSI** (Absci) — down double digits on AI pharma disruption fears (KeyBanc)
- **RXRX** (Recursion) — down double digits on AI pharma disruption fears (KeyBanc)
- **SDGR** (Schrodinger) — down double digits on AI pharma disruption fears (KeyBanc)
- **OWL** (Blue Owl Capital) — Emanuel battered stocks screen

#### Thematic / Infrastructure
- **AMD** (Advanced Micro Devices)
- **AMSC** (American Superconductor)
- **AVGO** (Broadcom)
- **BSX** (Boston Scientific)
- **CHKP** (Check Point Software) — JPM AI-Resilient: Cybersecurity
- **CLS** (Celestica)
- **CRWD** (CrowdStrike) — JPM AI-Resilient: Cybersecurity
- **CSGP** (CoStar Group) — JPM AI-Resilient: Enterprise
- **CSU** (Constellation Software)
- **CVNA** (Carvana)
- **DDOG** (Datadog) — JPM AI-Resilient: Data/Infrastructure
- **FROG** (JFrog) — JPM AI-Resilient: Enterprise
- **GWRE** (Guidewire Software) — JPM AI-Resilient: Enterprise
- **HUBS** (HubSpot)
- **INTA** (Intapp)
- **INTU** (Intuit)
- **LITE** (Lumentum)
- **LRCX** (Lam Research) — AI memory/equipment cycle winner (+40%)
- **META** (Meta Platforms)
- **NOW** (ServiceNow) — JPM AI-Resilient; "heavyweight opportunity" paired with MSFT
- **NVDA** (NVIDIA)
- **OKTA** (Okta) — JPM AI-Resilient: Enterprise
- **OUST** (Ouster) — Physical AI/Lidar, acquired StereoLabs
- **PANW** (Palo Alto Networks) — JPM AI-Resilient: Cybersecurity
- **QTWO** (Q2 Holdings) — JPM AI-Resilient: Enterprise
- **S** (SentinelOne) — JPM AI-Resilient: Cybersecurity
- **SailPoint** — JPM AI-Resilient: Enterprise
- **SNDK** (Sandisk) — memory cycle winner, doubled in 3mo
- **SNOW** (Snowflake) — JPM AI-Resilient: Data/Infrastructure
- **TTD** (The Trade Desk)
- **TWLO** (Twilio) — JPM AI-Resilient: Enterprise
- **TYL** (Tyler Technologies) — JPM AI-Resilient: Enterprise
- **VEEV** (Veeva Systems) — JPM AI-Resilient: Enterprise
- **WDAY** (Workday) — JPM AI-Resilient: Enterprise
- **ZS** (Zscaler) — JPM AI-Resilient: Cybersecurity

### Pipeline

| Stage | Tickers |
|-------|---------|
| Screened (awaiting analysis) | MSFT, UNH, IT |
| Under Analysis | NOW (screening complete — proceeding to statements), CRM (screening complete — proceeding to statements), PYPL (sentiment + statement + MD&A complete — decision pending) |
| Analyzed | AMZN |

---

## Trades

| Date | Ticker | Action | Price | Amount | Notes |
|------|--------|--------|-------|--------|-------|
| 2026-02-05 | AMZN | Buy | $222.71 | $4,999.84 | Individual ***4222. CapEx pivot to hyper-investment ($123B run-rate). Strong OCF ($116B), exceptional credit quality (Debt/OCF < 0.5). |

---

## Stock Context

### HUBG (Hub Group)
- **Incident**: Shares fell ~18% after disclosing a $77M financial reporting error (understated accounts payable and transportation costs).
- **Status**: Potential "fat pitch" or value trap depending on whether this is an isolated accounting lapse or indicative of deeper internal control failures.

### ICHR (Ichor Holdings)
- **Signal**: Stock jumped 35% on earnings beat and upbeat outlook.
- **Check**: "Glamour Metrics" trap. Need to validate if the price surge is supported by actual operating cash flow or just "upbeat outlook" in a reflexive sector.

### KD (Kyndryl)
- **Collapse (-55%)**: "Perfect Storm" of bad news triggering a massive confidence loss.
- **Triggers**: Simultaneous departure of CFO, General Counsel, and Global Controller + SEC voluntary document request regarding accounting.
- **Fundamentals**: Guidance flipped from growth (+1%) to decline (-2% to -3%). FCF forecast slashed from $550M to $350M.

### CRM (Salesforce)
- **Screening Summary** (Feb 11): Price $193, down -27% YoY, at 52-week low. P/E 18.3x vs. 5-yr avg 33.6x — a 46% discount. Brand name stock at historically cheap valuation.
- **EPS Concern**: EPS peaked at $10.19 (FY2025) and declined to $7.79 (FY2026, -24%). Unlike NOW, the decline is real — but CRM has beaten estimates every quarter (1-14% surprises), so the decline appears deliberate/expected by analysts. Forward estimates project recovery ($11.77 FY, $13.12 next FY).
- **Catalysts**: Emanuel battered stocks screen (high short interest, squeeze potential). Software Basket [Feb 11] — Goldman/Blackstone call selloff "overblown."
- **Key Questions for Statement Analysis**:
    1. Is OCF/FCF holding up despite the EPS decline? Or is margin erosion flowing through to cash?
    2. What's driving the EPS drop — investment spending, restructuring charges, or structural margin compression?
    3. Buyback activity — is management buying at these levels?

### IT (Gartner)
- **Screening Summary** (Feb 11): Price $160, down -62% YoY, at 52-week low. P/E 15.9x vs. 5-yr avg 32x — a 50% discount. Strong price-EPS correlation (0.76) historically.
- **AI-Fear Selloff**: Tagged as "data provider disruption thesis" — same narrative hitting CLVT, but IT has far stronger underlying fundamentals.
- **Critical Anomaly**: Q3 2025 EPS of $0.47 vs. $2.12 estimate (-77.8% miss). Surrounding quarters are normal ($2.71, $3.53, $3.36). Almost certainly a one-time charge — needs explanation before proceeding.
- **Key Questions for Statement Analysis**:
    1. What caused the Q3 2025 EPS collapse? (Restructuring, goodwill impairment, or operational?)
    2. If one-time, what is the normalized P/E? (Likely 12-13x for a historically 30x stock.)
    3. Is the AI disruption thesis valid for Gartner's enterprise advisory model, or is the moat stickier than the market fears?

### MSFT (Microsoft)
- **Context**: Transition from high-margin SaaS/Azure cash cows to massive GPU CapEx.
- **Risk**: LLM profitability unproven and currently unprofitable. Increased LLM efficiency could reduce anticipated demand for compute.
- **Bullish Sign**: Public admission of "Windows AI bloat" suggests focus on optimization and performance.
- **JPM "AI-Resilient" Pick**: Analysts argue -19% sell-off (3mo) on Azure/CapEx fears is "overdone." Grouped with ServiceNow (NOW) as a heavyweight opportunity.

### NOW (ServiceNow)
- **Screening Summary** (Feb 11): Price $106, down -33% YoY, at 52-week low. P/E 30x vs. 5-yr avg 80x — a 62% discount. Cheapest NOW has ever been on an earnings basis.
- **EPS Strength**: 5-year EPS CAGR ~40% ($0.92 -> $3.51). All 4 recent quarters beat estimates (3-16% surprises). Forward estimates project continued growth ($4.16 FY2026, $5.01 FY2027).
- **Catalysts**: JPM "AI-Resilient" pick — "heavyweight opportunity" paired with MSFT. Emanuel battered stocks screen (squeeze potential). Software Basket [Feb 11] — Goldman/Blackstone call selloff "overblown."
- **Central Question**: Does AI genuinely threaten NOW's workflow automation moat, or is this a brand name stock experiencing a solvable sentiment problem? Three independent institutional signals say the latter.
- **Key Questions for Statement Analysis**:
    1. Is OCF/FCF growth tracking EPS growth? Or is profitability an accounting artifact?
    2. Revenue quality — subscription vs. one-time, retention rates, RPO trends.
    3. What does the margin structure look like? Is operating leverage improving or is growth being bought?

### OUST (Ouster)
- **Event**: Acquired StereoLabs (camera maker/machine vision) to enable "sensing and perception for Physical AI" by pairing lidar with vision.
- **Performance**: +100% YoY, but down over past 6 months.

### PYPL (PayPal)
- **Thesis**: "Cannibal Stock" - market pricing it like a "melting ice cube" (~$40/share, terminal decline pricing), but fundamentals support margin of safety.
- **Key Metrics**: 7.5x Earnings, 15% FCF Yield, 23% ROIC. Structurally profitable.
- **Moat Argument**: Two-sided network effects (Consumer/Merchant) and transaction data advantage create high switching costs that are difficult for single-sided rails to replicate.
- **Capital Allocation Context**: A tale of two eras. Management deployed $9.2B (2020-2022) at peak valuations ($200-$300), destroying ~70% of that capital. Current $6B+ annual pace at ~$40 is mechanically increasing intrinsic value.
- **Execution Check**: Q4 Branded Checkout growth decelerated (5% → 1%). 2027 outlook withdrawn. Interim CEO admits: "Execution has not been what it needs to be."
- **Sentiment** (Feb 8): Near-universal bearishness.
- **Statement Analysis — Key Questions (all resolved Feb 10)**:
    1. Is OCF/FCF holding up despite the EPS miss? **Yes.** OCF $6.4B, FCF $5.6B, both above 5-yr avg.
    2. Branded vs. unbranded (Braintree) revenue mix and margin difference? **Branded growing faster.** PayPal/Venmo +$1.08B, Braintree +$150M. Deliberate Braintree pullback for "profitable growth."
    3. Buyback pace and capital allocation — still compelling at these levels? **$6.0B repurchased in 2025 (exceeds FCF). $13.9B authorization remaining.**
- **MD&A Analysis** (Feb 10): 10-K FY2025 confirms revenue mix improving, investment increasing (S&M +14%), cloud migration underway. GAAP diluted EPS $5.41. Dividend initiated ($0.56/yr). Merchant credit quality deteriorating (watch). Full thesis in `data/tickers/PYPL/PYPL_thesis_2026-02-10.md`.

### SPGI (S&P Global)
- **Signal**: Shares in bear market territory after mixed Q4 earnings failed to resolve AI-driven concerns.
- **Context**: High-quality brand name stock; potential divergence between long-term data moat durability and short-term sentiment.

### UNH (UnitedHealth Group)
- **Thesis**: Structural shift in healthcare economics. UNH and Medicare Advantage (MA) players facing "margin death" as CMS rate increases (~0.9%) fail to keep pace with sticky healthcare inflation (labor, drugs).
- **Key Insight**: CMS uses lagging formulas and is constrained by federal deficit math. Era of easy ~6% annual rate increases likely over.
- **Risk**: Traditional "spread pricing" models becoming unworkable. Success depends on flawless execution in cost control and risk adjustment, not policy tailwinds.

---

## Market & Thematic Context

### Big Tech: AI Demand Quotes (Q1/Q2 2026 Context)
- **Amazon**: "Monetizing capacity as fast as we can install it." Backlog $244B (+40% YoY). $200B CapEx predominant in AWS.
- **Google**: "Supply constrained even as we've been ramping up capacity." Backlog $240B (+55% QoQ).
- **Microsoft**: "Demand continues to exceed our supply." GitHub Copilot paid subscribers at 4.7M (+75% YoY). Commercial RPO at $625B.
- **Meta**: "Continue to be capacity constrained." 2026 CapEx range $115-$135B for Superintelligence Labs and core business.

### AI Spending & Memory Market (2026 Context)
- **CapEx**: Big 5 (GOOGL, META, AMZN, MSFT, ORCL) projected $715B spend (+60% YoY).
- **Memory Squeeze**: AI demand crowding out supply for PCs/Smartphones; Q1 prices +80-90%.
- **Cycle Winners**: Sandisk (SNDK, doubled in 3mo), Micron (MU, +60%), Lam Research (LRCX, +40% - equipment).
- **Software Dip**: Jefferies identifies price drops in SNOW, MSFT, INTU as attractive buying opportunities.

### Global Markets (Feb 2026)
- **Shift**: "Global Bull Market" (Truist). Rotation from U.S. dominance to Global Value/Small-cap (Europe, China, Japan).
- **Catalyst**: Weakening Dollar (-10% from 2022 highs) boosting foreign equity returns.
- **Data**: MSCI ACWI ex-U.S. surged 29% in 2025 (vs S&P 500 +16%). Nikkei 225 at fresh records.

### AI-Resilient Software (J.P. Morgan Screen)
- **Theme**: "Buy high-quality software at a discount." Reaction to AI competition fears is exaggerated.
- **Cybersecurity**: Palo Alto (PANW), CrowdStrike (CRWD), Zscaler (ZS), Check Point (CHKP), SentinelOne (S), Netskope.
- **Data/Infrastructure**: Snowflake (SNOW), Datadog (DDOG).
- **Enterprise/Verticals**: Twilio (TWLO), Okta (OKTA), Veeva (VEEV), Guidewire (GWRE), CoStar (CSGP), Tyler Tech (TYL), Q2 Holdings (QTWO), JFrog (FROG), SailPoint.

### Battered Stocks / Short Interest (Emanuel Screen)
- **Criteria**: Fall of ≥10% YTD and ≥30% over 12mo; short interest in ≥65th percentile of historic range.
- **Context**: High short interest creates potential for "take off" (squeeze) on positive news. Qualifiers include CRM, ADBE, NOW, SailPoint, WDAY, UNH, OWL.

### Healthcare Data Tools (KeyBanc)
- **Status**: ABCL, ABSI, RXRX, SDGR down double digits from peaks on fears AI will push data-centric pharma tools to the sidelines.
- **Asset**: Biologic data is "complex, higher-dimensional, and harder to standardize." Proprietary datasets viewed as significant moats.

---

## Open Items
- **SEC Filings Script — 10-Q Extraction Bug**: `scripts/ticker/sec_filings.py` failed to extract meaningful content from PYPL's 10-Q (Q3 2025). MD&A returned 14 words (just a page reference), Notes returned 376 words. Likely an HTML parsing issue with PayPal's specific 10-Q formatting. The 10-K extraction worked correctly (10,670 words MD&A, 3,546 words Notes). The 10-K Notes also had issues — XBRL-tagged dollar values were stripped, leaving "$" without amounts, and extraction captured only the tax/restructuring sections (missed earlier Notes). Needs investigation for future tickers.

## Open Decisions
- **Data File Synchronization (TBD)**: Current .gitignore tracks Daily analysis files but ignores raw data (JSON, ticker subdirectories).
    - **Current State**: Daily_Digest and Daily_Screening files sync via git. Raw JSON data does NOT sync.
    - **Options**: (1) Keep current (2) Track all data files (3) Hybrid snapshots (4) External storage
    - **Decision needed**: Depends on workflow - single environment vs frequent platform switching.
